Block listing Interim Review
Source: RNS|
|
10 March 2020 |
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
|
Name of applicant: |
Advanced Medical Solutions Group plc |
|||
|
Name of scheme: |
Block Scheme for: 1. Deferred Share Bonus Scheme 2. Enterprise Management Incentive Scheme 3. Company Share Option Plan 4. Unapproved Executive Share Option Scheme 5. Long Term Incentive Plan 6. Deferred Annual Bonus Scheme |
|||
|
Period of return: |
From: |
6 September 2019 |
To: |
6 March 2020 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1. 661,554 2. 38,000 3. 323,733 4. 1,037,228 5. 776,034 6. 407,111 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil 3. Nil 4. Nil 5. Nil 6. Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
1. 34,463 2. 23,000 3. Nil 4. 83,031 5. Nil 6. Nil
|
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1. 627,091 2. 15,000 3. 323,733 4. 954,197 5. 776,034 6. 407,111 |
|||
|
Number and class of securities originally listed and the date of admission: |
4,476,264 ordinary shares of 5p each on 6 September 2018
|
|||
|
Name of contact: |
Eddie Johnson |
|
Telephone number of contact: |
01606 545506 |
For further information, please visit www.admedsol.com or contact:
|
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
|
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer |
|
|
|
|
|
Consilium Strategic Communications |
Tel: +44 (0) 20 3709 5700 |
|
Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser |
|
|
|
|
|
Investec Bank PLC - Nominated Adviser & Broker |
Tel: +44 (0) 20 7597 5970 |
|
Daniel Adams / Patrick Robb / Gary Clarence |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
